Allison Malkin
Investor Relations Representative, ICR
Replay available
Waldencast plc (NASDAQ: WALD) Q3 2024 earnings conference call, held 2024-11-21. Replay captured from the company's public earnings webcast.

Investor Relations Representative, ICR
Chief Financial Officer
Founder and Chief Executive Officer
Analyst, TD Cal
Analyst, Cannon Quarter
Analyst, Telsey Advisory Group
Analyst, DA Davidson
Watch the replay and follow the connected company analysis, news, and investor updates for Waldencast Plc.
WEBVTT 00:00:00.049 -- 00:00:05.313 Greetings, and welcome to the WaldenCast third quarter and first nine months 2024 earnings 00:00:05.313 -- 00:00:09.597 call. At this time, all participants are in listen-only mode. 00:00:09.597 -- 00:00:13.621 If anyone should require operator assistance, please press star zero on your telephone 00:00:13.621 -- 00:00:15.182 keypad. 00:00:15.182 -- 00:00:19.205 A question and answer session will follow the formal presentation. 00:00:19.205 -- 00:00:23.249 You may be placed in the question queue at any time by pressing star one on your telephone 00:00:23.249 -- 00:00:27.913 keypad, and we ask you to please ask one question, one follow-up, then return to the 00:00:27.913 -- 00:00:29.654 queue. 00:00:29.654 -- 00:00:32.856 As a reminder, this conference is being recorded. 00:00:32.856 -- 00:00:36.537 It's now my pleasure to turn the call over to Allison Malkin with ICR. 00:00:36.537 -- 00:00:38.418 Allison, please go ahead. 00:00:38.418 -- 00:00:44.141 Thank you, and welcome to the WaldenCast PLC Third Quarter Fiscal 2024 00:00:44.141 -- 00:00:49.924 Earnings Call. With me today are Michelle Broussette, Founder and Chief Executive Officer, 00:00:49.924 -- 00:00:53.326 and then Will Manfredi, Chief Financial Officer. 00:00:53.326 -- 00:00:58.107 For today's call, Michelle will begin with an update on our business and vision. 00:00:58.107 -- 00:01:02.690 discuss the company's performance within the context of the beauty market. 00:01:02.690 -- 00:01:07.534 Manuel will follow with a review of the third quarter and year-to-date performance and 00:01:07.534 -- 00:01:12.618 provide our fiscal 2024 outlook. Following this, Michelle will share 00:01:12.618 -- 00:01:18.562 the strategic growth initiatives for our milk makeup and Obagi medical ...